Columbus, OH 的 多發性硬化症 臨床試驗
7 項針對 多發性硬化症 的研究正在 Columbus（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
招募中2 期
- Riverside Methodist Hospital, Columbus
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
招募中2 期
- Local Institution - Site 104, Columbus
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
招募中觀察性研究
- TG Therapeutics Investigational Trial Site, Columbus
- TG Therapeutics Investigational Trial Site, Columbus
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Ohio State University Comprehensive Cancer Center, Columbus
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
招募中3 期
- The Ohio State University- Site Number : 8400009, Columbus
- The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- The Ohio State University, Department of Psychiatry, Columbus
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
招募中1 期
- TG Therapeutics Investigational Trial Site, Columbus
其他城市的 多發性硬化症 試驗
- New York City, NY17 項研究
- Chicago, IL15 項研究
- Boston, MA14 項研究
- Washington, DC13 項研究
- Cleveland, OH9 項研究
- St. Louis, MO8 項研究
- Kansas City, KS8 項研究
- Birmingham, AL8 項研究
- San Francisco, CA8 項研究
- Aurora, CO7 項研究
- Baltimore, MD7 項研究
- Houston, TX6 項研究
Columbus 的其他研究
- 非小細胞肺癌55 項研究
- 乳癌39 項研究
- 卵巢癌39 項研究
- 癌症（所有類型）38 項研究
- 肺癌36 項研究
- 急性髓系白血病34 項研究
- 慢性淋巴性白血病28 項研究
- 轉移性癌症27 項研究
- 子宮內膜癌25 項研究
- 前列腺癌24 項研究
- 多發性骨髓瘤24 項研究
- 大腸直腸癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月2日。各研究自行設定資格標準；由研究團隊決定參與者資格。